| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
3,780,000 |
| Market
Cap: |
8.24(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1 - $2.92 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AYTU BioPharma is a pharmaceutical company focused on commercializing therapeutics and consumer health products and developing therapeutics for pediatric-onset or difficult-to-treat diseases. Co. operates through two business segments: the BioPharma segment, consisting of prescription pharmaceutical products; and the Consumer Health segment, which consists of various consumer healthcare products. Co. also has two product candidates in development, AR101 (enzastaurin) for the treatment of vascular Ehlers-Danlos Syndrome and Healight (endotracheal ultraviolet light catheter) for the treatment of severe, difficult-to-treat respiratory infections.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
83,332 |
98,332 |
98,332 |
98,332 |
| Total Buy Value |
$124,998 |
$144,498 |
$144,498 |
$144,498 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
3 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Disbrow Joshua R. |
Chief Executive Officer |
• • – |
2025-06-09 |
4 |
B |
$1.50 |
$99,999 |
D/D |
66,666 |
153,257 |
2.74 |
-0% |
|
| Disbrow Jarrett |
Chief Business Officer |
• • – |
2025-06-09 |
4 |
B |
$1.50 |
$24,999 |
D/D |
16,666 |
29,462 |
2.74 |
-0% |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2025-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
209 |
23,602 |
|
- |
|
| Disbrow Joshua R. |
Chief Executive Officer |
• • – |
2025-02-28 |
4 |
B |
$1.30 |
$19,500 |
D/D |
15,000 |
86,591 |
2.74 |
63% |
|
| Selhorn Ryan J |
Chief Financial Officer |
• • – |
2025-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
105 |
16,000 |
|
- |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2024-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
23,393 |
|
- |
|
| Selhorn Ryan J |
Chief Financial Officer |
• – – |
2024-11-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,895 |
|
-28% |
|
| Selhorn Ryan J |
Chief Financial Officer |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
15,895 |
|
- |
|
| Donofrio John Jr. |
|
• • – |
2024-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
3,762 |
|
- |
|
| Dockery Carl |
|
• • – |
2024-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
10,440 |
|
- |
|
| Jain Abhinav |
|
• • – |
2024-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
9,500 |
|
- |
|
| Liu Vivian H |
|
• • – |
2024-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
9,825 |
|
- |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2024-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
209 |
23,185 |
|
- |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2024-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,976 |
|
- |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,768 |
|
- |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
209 |
22,560 |
|
- |
|
| Pyszczymuka Greg |
Chief Commercial Officer |
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,351 |
|
- |
|
| Jain Abhinav |
|
• • – |
2023-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
8,000 |
|
- |
|
| Liu Vivian H |
|
• • – |
2023-08-11 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,500 |
8,325 |
|
- |
|
| Liu Vivian H |
|
• • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
1,841 |
|
- |
|
| Donofrio John Jr. |
|
• • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
2,262 |
|
- |
|
| Jain Abhinav |
|
• • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
1,500 |
|
- |
|
| Dockery Carl |
|
• • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
8,940 |
|
- |
|
| Pyszczymuka Greg |
Chief Commerical Officer |
• • – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,143 |
|
- |
|
| Disbrow Joshua R. |
Chief Executive Officer |
• • – |
2023-06-14 |
4 |
B |
$1.86 |
$26,079 |
D/D |
14,000 |
71,591 |
0.01 |
68% |
|
131 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.08 (3.81%) 
